| scholarly article | Q13442814 |
| P50 | author | Olugbenga Okusanya | Q81406187 |
| P2093 | author name string | Guanjun Cheng | |
| Veena Kapoor | |||
| Evgeniy Eruslanov | |||
| Jack Jiang | |||
| Pratik Bhojnagarwala | |||
| Sunil Singhal | |||
| Jarrod D Predina | |||
| Jon G Quatromoni | |||
| Ryan P Judy | |||
| Elizabeth M De Jesus | |||
| P2860 | cites work | Esophageal adenocarcinoma in "mice and men": back to basics! | Q37290141 |
| Esophagogastric cancer: targeted agents. | Q37685366 | ||
| The use of the orthotopic model to validate antivascular therapies for cancer | Q37920823 | ||
| Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor | Q38473933 | ||
| Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice. | Q39215847 | ||
| Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats | Q39255662 | ||
| The establishment of a new mouse model with orthotopic esophageal cancer showing the esophageal stricture. | Q39740106 | ||
| Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model | Q39784658 | ||
| B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models | Q39984600 | ||
| HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function | Q39998431 | ||
| Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer | Q40568847 | ||
| Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. | Q40593964 | ||
| Locoregional cellular immunotherapy for patients with advanced esophageal cancer. | Q40609518 | ||
| Modulation of tumor cell response to chemotherapy by the organ environment | Q40630947 | ||
| A novel orthotopic implantation model of human esophageal carcinoma in nude rats: CD44H mediates cancer cell invasion in vitro and in vivo | Q40812518 | ||
| The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach | Q42437421 | ||
| Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture | Q42615524 | ||
| Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. | Q42810754 | ||
| Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis | Q42951422 | ||
| Epidemiology and biology of esophageal cancer. | Q43124349 | ||
| Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine | Q43409838 | ||
| Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. | Q44022873 | ||
| Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma | Q45858736 | ||
| Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome. | Q50149962 | ||
| Esophagogastric adenocarcinoma in an E1A/E1B transgenic model involves p53 disruption | Q52538847 | ||
| Photodynamic therapy and cancer | Q60302072 | ||
| Viral recombinant vaccines to the E6 and E7 antigens of HPV-16 | Q73693192 | ||
| Selective embolization of thyroid arteries as a preresective and palliative treatment of thyroid cancer | Q81392111 | ||
| Cancer immunotherapy | Q81925442 | ||
| Global cancer statistics | Q22241238 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
| Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan). | Q33796126 | ||
| A mouse model of human oral-esophageal cancer | Q34796816 | ||
| A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer | Q35143202 | ||
| Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models | Q35549847 | ||
| Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages | Q35761435 | ||
| Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists | Q35880879 | ||
| The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation | Q36098246 | ||
| Lung metastases after liver resection or cryotherapy for hepatic metastasis from colorectal cancer--there is a difference! | Q36253257 | ||
| Update on cryotherapy for prostate cancer in 2006. | Q36470700 | ||
| Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery | Q36583022 | ||
| Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data | Q36771602 | ||
| P433 | issue | 5 | |
| P921 | main subject | Adenoviridae | Q193447 |
| immunotherapy | Q1427096 | ||
| murine model | Q122890741 | ||
| P304 | page(s) | 283-292 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Journal of Immunotherapy | Q15763946 |
| P1476 | title | Adenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer | |
| P478 | volume | 37 |
| Q26783904 | Esophageal Cancer: Insights From Mouse Models |
| Q27321510 | Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse Model |
| Q34414917 | High GPX1 expression promotes esophageal squamous cell carcinoma invasion, migration, proliferation and cisplatin-resistance but can be reduced by vitamin D |
| Q52353493 | Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses. |
| Q52707505 | Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma. |
Search more.